A nurse is caring for a client who has dysphagia following a stroke.
The nurse should recommend a referral to which of the following members of the interdisciplinary team?

Choice A rationale

Echinacea has immunomodulatory effects, potentially boosting immunity. While it interacts with some medications, its usage does not pose significant risks with anticoagulants like enoxaparin unless combined with other supplements or medications causing immune changes.

Choice B rationale

Ginkgo biloba increases the risk of bleeding due to its antiplatelet effects, which can compound the anticoagulant effects of enoxaparin. This interaction requires reporting to the provider to adjust or monitor anticoagulant therapy accordingly.

Choice C rationale

Probiotics support gut health but do not interact significantly with anticoagulants or alter coagulation parameters. Their usage can generally be continued unless specific contraindications arise with concurrent conditions or medications.

Choice D rationale

Flaxseed powder is a source of omega-3 fatty acids, which may have mild anticoagulant effects. However, this interaction is not typically strong enough to warrant reporting unless combined with other supplements affecting coagulation.

Choice A rationale

Pain patches containing medications like fentanyl are designed for continuous absorption over 72 hours and should not be removed at bedtime. Removing the patch prematurely could lead to a sudden drop in medication levels, compromising pain control. The pharmacokinetics of transdermal patches ensure a steady release of analgesic agents without requiring frequent application.

Choice B rationale

Around-the-clock analgesia provides consistent plasma drug levels, ensuring better pain control compared to as-needed dosing. By preventing peaks and troughs in medication levels, this approach enhances efficacy and improves the client’s quality of life. Studies confirm this approach reduces breakthrough pain in terminal cancer patients.

Choice C rationale

Intramuscular injections are not the preferred route for long-term pain management due to their variable absorption, potential for tissue damage, and patient discomfort. Oral, transdermal, or intravenous routes are safer, more effective options for sustained analgesia.

Choice D rationale

Tolerance, a normal physiological response, does not necessitate dose reduction but rather dose adjustment to maintain therapeutic effects. Reducing the dose can result in inadequate pain relief and increased patient suffering. Evidence supports dose titration based on pain severity and patient needs.